PENTINGNYA MENDETEKSI ORAL LEUKOPLAKIA SEBAGAI ORAL POTENTIALLY MALIGNANT DISORDERS (LAPORAN KASUS)

Authors

  • Revi Nelonda Residen Ilmu Penyakit Mulut Fakultas Kedokteran Gigi Universitas Padjadjaran
  • Tenny Setiani Dewi Departemen Ilmu Penyakit Mulut Fakultas Kedokteran Gigi Universitas Padjadjaran

DOI:

https://doi.org/10.33854/jbd.v5i2.162

Keywords:

Oral potentially malignant disorders, oral leukoplakia, malignancy

Abstract

Oral Leukoplakia (OL) is white plaque lesion in oral mucosa that cannot be scraped and one of Oral Potentially Malignant Disorder (OPMD) with incidence about 2.5% of all populations in the world. The most case of oral squamous cell carcinoma are preceded by OPMD. The aim of this case report is to understand the importance of detection oral lesion that could potentially become malignancy. A 28-year-old male patient complained of sores on his tongue that had not healed for 2 months. Intraoral examination obtained red and white lesion on the left lateral tongue: shallow reddish ulcer with irregular border in region 35-36, followed by unscrapable white plaque lesion with slight induration in region 37-38. Hematological examination showed normal range. According anamnesis and clinical examination, diagnosis of traumatic ulcer and OL were made. Patients were treated with multivitamins and antiseptic mouthwash. Histopathological examination results from lesion biopsies show a hyperplastic mass, parakeratosis and a tissue with polymorphic form, a hyperchromatic nucleus of cells associated with histopathologic criteria of squamous cell carcinomas with well differentiation. The patient was referred to the Hemato-oncology Department for chemotherapy. There are two important parameters should be considered when evaluating the potential for malignant change of OL that is when finding white lesions with or without red lesions should always be suspected as OPMD and always confirm it by histopathological examination as early as possible. Accurate examination and histopathologic examination is essential to obtain a good prognosis in OPMD.

References

Nureddin A. New definition for leukoplakia and reclassification of leukoplakias as separated disease entities. Adv Dent Oral Helath. 2018;7(4):1–6. Doi: 10.1016/j.bjorl.2016.12.005

Mohammed F, AT F. Oral leukoplakia. StarPearls, Teasure Isl. 2017;(October):2–6.

Irani S. Pre-cancerous lesions in the oral and maxillofacial region : A literature review with special focus on etiopathogenesis. Iran J Pathol. 2016;11(4):303–22.

Mortazavi H, Baharvand M, Mehdipour M. Oral potentially malignant disorders: An overview of more than 20 entities. J od Dent Res Dent Clin Dent Prospect. 2014;8(1):9–13. Doi: 10.5681/joddd.2014.002

Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P. Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Dis Complicat. 2006;42:987–93. Doi: 10.1016/j.oraloncology.2005.12.014

Wang T, Chiu Y, Chen Y, Wang Y, Yu H, Yu C, et al. Malignant transformation of Taiwanese patients with oral leukoplakia : A nationwide population-based retrospective cohort study. J Formos Med Assoc. 2018;1–7. Doi : 10.1016/j.jfma.2018.01.017

Kuribayashi Y, Tsushima F, Morita K, Matsumoto K, Sakurai J, Uesugi A, et al. Long-term outcome of non-surgical treatment in patients with oral leukoplakia. Oral Oncol. 2015;51(11):1020–5.Doi: 10.1016/j.oraloncology.2015.09.004

Pathology O. Oral leukoplakia , the ongoing discussion on definition and terminology. J Sect Oral Med Pathol Publ Types Rev. 2015;20(6):e685-692. Doi: 10.4317/medoral.21007

Mccullough MJ, Prasad G, Farah CS. Oral mucosal malignancy and potentially malignant lesions : an update on the epidemiology , risk factors , diagnosis and management. Aust Dent J. 2010;55(1):61–5. Doi: 10.1111/j.1834-7819.2010.01200.x

Mds PP, Mds NA. Inter-observer agreement in grading oral epithelial dysplasia – A systematic review. J Oral Maxillofac Surgery, Med Pathol. 2014;1–5. Doi: 10.1016/j.ajoms.2014.01.006

Smith J, Rattay T, Mcconkey C, Helliwell T, Mehanna H. Biomarkers in dysplasia of the oral cavity : A systematic review. Oral Oncol. 2009;45(8):647–53. Doi:10.1016/j.oraloncology.2009.02.006

Waal I van der. Oral potentially malignant disorders : Is malignant transformation predictable and preventable ? J Sect Oral Med Pathol Publ Types Rev. 2014;19(4):1–5. Doi: 10.4317/medoral.20205

Kolenko Y. Malignant transformation of oral leukoplakia and oral lichen planus : a retrospective cohort study of 293 Ukrainian patients. J Educ Heal Sport. 2017;7(3):273–9. Doi: 10.5281/zenodo.290548

Bewley AF, Farwell DG. Oral leukoplakia and oral cavity squamous cell carcinoma. Clin Dermatol. 2017;35(5):461–7. Doi: 10.1016/j.clindermatol.2017.06.008

Kanneppady SK, Kanneppady SS, Lakshman AR. An insight into oral leukoplakia. Mod App dent Oral Heal. 2018;1(5):1–4.

Warnakulasuriya S, Johnson NW, Waal I Van Der. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–80. Doi: 10.1111/j.1600-0714.2007.00582.x

Diz P, Gorsky M, Johnson NW, Kragelund C, Manfredi M, Thongprasom K, et al. Oral leukoplakia and erythroplakia : a protocol for diagnosis and management. EOAMDiagnostic Ther Protoc.

Nair DR, Pruthy R, Pawar U, Pankaj, Chaturvedi. Oral cancer : Premalignant conditions and screening – an update. J Cancer Res Ther. 2012;8(2):57–66. Doi: 10.4103/0973-1482.92217

Gene M, Ying J, Wang F, Lin J. Human papillomavirus 16 as a risk factor for oral leukoplakia : A meta-analysis. Meta Gene.2017;12(426):43–6. Doi: 10.1016/j.mgene.2017.01.001

Deliverska EG, Petkova M. Management of oral leukoplakia analysis of the literature. J IMAB. 2017;23(1):1495–504.

González-Moles MÁ. The use of topical corticoids in oral pathology. J Oral Med , Pathol. 2010;15(6):827–31.

Carrard VC, Waal I Van Der. A clinical diagnosis of oral leukoplakia ; A guide for dentists. Med oral Patol cir Bucal. 2018;23(1):e59-64. Doi: 10.4317/medoral.22292

Kayalvizhi EB, Lakshman VL, Sitra G, Yoga S, Kanmani R, Megalai N. Oral leukoplakia : A review and its update. Jouranl Med Radiol Pathol Surg. 2016;2:18–22. Doi: 10.15713/ins.jmrps.52

Clinical H, Hospital CD, Pathology M, Yorkshire S. Oral malignancy and premalignancy. Br J Hosp. 2016;77(4):232–9.

Akbari ME, Moghadam SA, Moghadam FA. Malignant tumors of tongue in Iranian population. Iran J cancer Prev. 2016;9(4):e4467. Doi: 10.17795/ijcp-4467.

Watabe Y, Nomura T, Onda T, Yakushiji T, Yamamoto N, Ohata H, et al. Malignant transformation of oral leukoplakia with a focus on low-grade dysplasia. J Oral Maxillofac Surgery, Med Pathol. 2016;28(1):26–9. Doi: 10.1016/j.ajoms.2015.02.007

Shenkin A. Micronutrients in health and disease. Postgr Med J. 2006;82:559–68. Doi: 10.1136/pgmj.2006.047670

Willershausen B, Ross A, Försch M, Willershausen I, Mohaupt P, Callaway A. The influence of micronutrients on oral and general health. Eur J Med Res. 2011;16(11):514.

Koury MJ. New insight into erythropoiesis : The roles of folate, vitamin B12, and iron. Annu Rev Nutr. 2004;24:105–31. Doi: 10.1146/annurev.nutr.24.012003.132306

Bhattacharya PT, Misra SR, Hussain M. Nutritional aspects of essential trace elements in oral health and disease : An extensive review. Hindawi Publ Corp Sci. 2016;ID 5464373:1–12. Doi: 10.1155/2016/5464373

Sankari LS. Role of nutrition in oral diseases. J Orofac Sci. 2014;(March 2011):35–9.

Chang JYF, Wang YP, Wu YC, Cheng SJ, Chen HM, Sun A. Blood profile of oral mucosal disease patients with both vitamin B1 and iron deficiencies. J Formos Med Assoc. 2015;114(6):532–8.

Jaber MA. Serum levels of folate and vitamin B 12 in oral epithelial dysplasia. Dent Oral Craniofacial Res. 2015;1(1):10–4. Doi: 10.15761/DOCR.1000103

Nagao T, Warnakulasuriya S, Nakamura T, Kato S, Yamamoto K, Fukano H. Treatment of oral leukoplakia with a low-dose of betacarotene and vitamin C suplements. Int J cancer. 2015;136:1708–17. Doi: 10.1002/ijc.29156

Downloads

Published

2019-04-08

Issue

Volume 5, Nomor 2, Desember 2018

Section

Case Report

License

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).